Carclo plc
09 May 2003
For Immediate Release 9 May 2003
Carclo plc
Proposed £6.4 million Property Sale of Acre Mills Site
On 31 March 2003, Carclo plc ('Carclo' or the 'Group') announced that it had
exchanged contracts, subject to shareholders' approval, for the sale of its Acre
Mills site in Huddersfield (the 'Site') to The Calderdale and Huddersfield
National Health Service Trust for a total cash consideration of £6.4 million
(the 'Sale').
The total consideration of £6.4 million will give rise to a profit on Sale
(after costs) of £3.1m increasing the net assets of the Group by the same
amount. The net proceeds from the Sale will be used to reduce the amount drawn
on the Group's overdraft facility. The total amount of the Group's banking
facilities will remain unchanged following the Sale, hence its financial
flexibility will be increased.
A circular to shareholders, providing further information on the Sale and
containing a notice of the extraordinary general meeting to approve the
transaction, will be posted to shareholders today. A copy of the circular will
shortly be available for inspection at the UK Listing Authority Document viewing
facility which is situated at: The Financial Services Authority, 25 The North
Colonnade, Canary Wharf, London, E14 5HS.
Current trading
Carclo provided a trading update as part of its announcement on 31 March 2003.
Since then, the businesses have traded in line with management's expectations
and the Board remains confident in the prospects for the Group, following the
Sale, for the current financial year.
Expected timetable
Posting of shareholder circular 9 May 2003
Last time and date for receipt of Forms of Proxy 10 a.m., 25 May 2003
Extraordinary General Meeting 10 a.m., 27 May 2003
Expected date for completion of the Sale 3 June 2003
Enquiries
Carclo plc
Chris Mawe, Finance Director 01924 330 500
Weber Shandwick Square Mile
Richard Hews/ Susanne Walker 020 7067 0700
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.